Metabolic/hypoxial axis predicts tamoxifen resistance in breast cancer. [PDF]
Azzam HN +5 more
europepmc +1 more source
Lycorine weakens tamoxifen resistance of breast cancer via abrogating HAGLR-mediated epigenetic suppression on VGLL4 by DNMT1. [PDF]
Zhai J, Jiang JF, Shi L.
europepmc +1 more source
Invasive lobular carcinoma: integrated multi-omics analysis reveals silencing of Argininosuccinate synthase and upregulation of nucleotide biosynthesis in tamoxifen resistance. [PDF]
Gupta A +10 more
europepmc +1 more source
Candidate Oligo Therapeutic Target, miR-330-3p, Induces Tamoxifen Resistance in Estrogen Receptor-Positive Breast Cancer Cells via HDAC4. [PDF]
Zhang M +5 more
europepmc +1 more source
ATP6AP1 promotes cell proliferation and tamoxifen resistance in luminal breast cancer by inducing autophagy. [PDF]
Yan Z +7 more
europepmc +1 more source
High expression of autophagy-related gene <i>EIF4EBP1</i> could promote tamoxifen resistance and predict poor prognosis in breast cancer. [PDF]
Yang S +8 more
europepmc +1 more source
Mechanisms for acquired tamoxifen resistance
openaire +1 more source
Lycorine affects tamoxifen resistance of breast cancer via m6A-based HAGLR. [PDF]
Shi L, Jiang JF, Zhai J.
europepmc +1 more source
GDNF-RET signaling and EGR1 form a positive feedback loop that promotes tamoxifen resistance via cyclin D1. [PDF]
Marks BA +6 more
europepmc +1 more source
ZMIZ1 lactylation induces tamoxifen resistance in breast cancer through increasing transcriptional activity of Nanog to impact cell stemness and cholesterol uptake. [PDF]
Liu Y +7 more
europepmc +1 more source

